Home » News » The Astrazeneca Vaccine Is Safe For Use – EMA

The Astrazeneca Vaccine Is Safe For Use – EMA

Coronavirus Nigeria

Coronavirus Nigeria

European Medical Agency, EMA has come out to say that the Astrazeneca vaccine for coronavirus is safe for use.

The agency recently had its say via
a statement by the National Primary Health Care Development Agency through its Head, Public Relations Unit, Mohammad Ohitoto.

According to him, this conclusion was reached after a thorough and scientific investigation, so the rumors should be ignored henceforth.

He added that the vaccine is not in any way associated with higher risk of blood clots as reports have been suggesting.

His words, “Following a thorough and scientific investigation, the EMA reaffirmed the vaccine is safe and effective.”

“Countries across Europe including Germany, France and Spain are today resuming administering the AstraZeneca vaccine.”

”The World Health Organization also reaffirmed the safety and efficacy of the AstraZeneca vaccine, along with the UK medical regulator, the Medicines and Healthcare products Regulatory Agency.”

“The UK also reports it has not observed increased rates of blood clotting, and the UK has administered the highest number of AstraZeneca vaccines globally by a significant margin, to more than one-third of its population.”

“According to the Executive Director/CEO National Primary Health Care Development Agency, NPHCDA, Dr. Faisal Shuaib, EMA’s findings and the restart of AstraZeneca use in Europe is very good news which we hope will entirely reassure all Nigerians who have been concerned in recent days as we followed the developments in European countries.”

“France’s Prime Minister Jean Castex has announced he will receive the AstraZeneca vaccine today, Friday. UK Prime Minister Boris Johnson also announced he will receive the AstraZeneca vaccine today.”


Follow NaijaVibe


NaijaVibe HoT DOWNLOAD
👇

Mani LaPussH – ExClusive


TareeQ – Medicine


NaijaVibe

Leave a Reply

Your email address will not be published. Required fields are marked *

*